Neuphoria Therapeutics Inc. (NEUP)

3.77USD +0.27% (+0.01)

Over 1M: -1.3%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

3.8 3.9
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q1 '24 — Operating Income: -5.5M Q1 '24 — Net Income: -5.5M Q2 '24 — Operating Income: -4.6M Q2 '24 — Net Income: -4.6M Q3 '24 — Operating Income: -2.4M Q3 '24 — Net Income: -2.8M Q4 '24 — Operating Income: -5.5M Q4 '24 — Net Income: -2.7M Q1 '25 — Operating Income: -3.6M Q1 '25 — Net Income: -804.8K Q2 '25 — Operating Income: -3.7M Q2 '25 — Net Income: -1.9M Q3 '25 — Operating Income: 12M Q3 '25 — Net Income: 11.3M Q4 '25 — Operating Income: -5.8M Q1 '26 — Operating Income: -5.7M Q1 '26 — Net Income: -9.9M Q2 '26 — Operating Income: -4.1M Q2 '26 — Net Income: 1.9M Q3 '26 — Operating Income: -1.2M Q3 '26 — Net Income: -505.1K -5M 0 5M 10M 15M
Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26
Operating Income Free Cash Flow Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.3
OE margin -112.0%
Oper. margin -107.1%
ROIC -132.6%
ROA -1.1%
ROE -1.3%
Accruals 48.2%
EBITDA margin -102.9%
FCF margin -109.6%
OCF margin -109.6%
ROCE -50.3%
Capex / sales —
Gross margin —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

5.7
EV/Sales 0.06×
EV/OE -0.053×
P/B 0.69×
P/C 1.0×
FCF yield -84.2%
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

0.5
RPO / sales —
RPO growth —
Segment HHI —

0 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.8
Current ratio 14.3×
ND/EBITDA 20.8
Interest cover -961.4×
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 14.3×
Cash runway 1.1 yr
Cash / Debt —
F-score —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Shares change +95.1%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Sales Q/Q —
Sales/sh Y/Y —

1 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.